Seeking Alpha

NephroGenex (NRX)

From other sites
Company Description
NephroGenex Inc is a drug development company. The Company is engaged in developing novel therapies for kidney disease. It has commercial rights to Pyridorin and conducted a Phase 2b clinical study in diabetic nephropathy patients.
Sector: Healthcare
Industry: Biotechnology
Country: United States